SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.55-0.6%11:09 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DaiS who wrote (2838)5/24/1998 9:55:00 AM
From: BigKNY3   of 9523
 
Dai << What I found sobering also was the recent report of the old man in his seventies who committed suicide in the placebo group. Perhaps so despairing that this new pill, his last salvation failed for him. >>

Dai, it is very doubtful that the suicide was related in anyway with despair over his clinical trial pill.

Every patient participating in a active drug/placebo study understands there is a 50% probability that they will be on placebo for a period of time and signs appropriate documents. Moreover, as described in the New England Journal of Medicine article, most patients in the Viagra studies were offered to be evaluated on active drug after the initial placebo phase was completed via an open label extension study. nejm.org

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext